The American College of Physicians has issued a set of recommendations to clarify the potential benefits and harms of testosterone therapy in men with age-related low testosterone.
Testosterone replacement is associated with an improvement in body composition among younger male cancer survivors with low-normal morning total serum testosterone.
Despite research suggesting that there may be increased cardiovascular risk from off-label prescription testosterone use, usage in men with coronary artery disease remains higher than in men without coronary artery disease.
Increased ibuprofen administration elevates LH and decreases testosterone to LH and inhibin B to FSH ratios in young adult men.
Men 65 years of age and older who received 1 year of testosterone therapy reported better mood and fewer depressive symptoms.
Researchers found 512 incident and 478 recurrent fibroid cases in patients with high testosterone and high estradiol.
There is too little evidence to continue prescribing testosterone therapy to female patients.
Chemicals found in many household products may reduce androgen levels in both sexes.
Testosterone levels were lower after sleep loss than after more appropriate rest intervals, with the effect of restricted sleep especially apparent between 2 pm and 10 pm.
Fortesta is a topical gel formulation of the androgen testosterone, indicated as replacement therapy in men for conditions associated with a deficiency or absence of the endogenous hormone.
